Cingulate (CING) Short Interest Ratio & Short Volume $4.32 +0.02 (+0.47%) Closing price 05/2/2025 03:59 PM EasternExtended Trading$4.28 -0.04 (-0.93%) As of 05/2/2025 04:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Cingulate Short Interest DataCingulate (CING) has a short interest of 171,600 shares, representing 4.50% of the float (the number of shares available for trading by the public). This marks a 21.70% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.7, indicating that it would take 1.7 days of the average trading volume of 1.08 million shares to cover all short positions.Current Short Interest171,600 sharesPrevious Short Interest141,000 sharesChange Vs. Previous Month+21.70%Dollar Volume Sold Short$743,028.00Short Interest Ratio1.7 Days to CoverLast Record DateApril 15, 2025Outstanding Shares3,941,000 sharesFloat Size3,810,000 sharesShort Percent of Float4.50%Today's Trading Volume39,054 sharesAverage Trading Volume1,077,252 sharesToday's Volume Vs. Average4% Short Selling Cingulate? Sign up to receive the latest short interest report for Cingulate and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCING Short Interest Over TimeCING Days to Cover Over TimeCING Percentage of Float Shorted Over Time Cingulate Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2025171,600 shares $743,028.00 +21.7%4.5%1.7 $4.33 3/31/2025141,000 shares $606,300.00 +51.8%3.9%1.1 $4.30 3/15/202592,900 shares $333,511.00 -22.1%3.0%0.7 $3.59 2/28/2025119,200 shares $491,104.00 -10.6%3.9%0.9 $4.12 2/15/2025133,400 shares $601,634.00 +24.8%4.3%0.9 $4.51 1/31/2025106,900 shares $486,395.00 -30.1%3.5%0.6 $4.55 1/15/2025153,000 shares $722,160.00 +34.6%4.9%0.9 $4.72 12/31/2024113,700 shares $560,541.00 +4.9%3.7%0.7 $4.93 12/15/2024108,400 shares $456,364.00 -24.3%3.5%0.8 $4.21 11/30/2024143,100 shares $623,916.00 +85.4%4.6%0.8 $4.36 Get the Latest News and Ratings for CING and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cingulate and its competitors with MarketBeat's FREE daily newsletter. 11/15/202477,200 shares $324,240.00 -13.5%2.5%0.2 $4.20 10/31/202489,200 shares $360,368.00 +132.9%4.4%0 $4.04 10/15/202438,300 shares $170,435.00 +37.3%1.9%0 $4.45 9/30/202427,900 shares $140,616.00 -74.4%1.4%0 $5.04 9/15/2024108,800 shares $587,520.00 -46.9%5.4%0 $5.40 8/31/2024205,000 shares $1.62 million +297.3%11.1%0.1 $7.89 8/15/202451,600 shares $247,680.00 +521.7%3.5%0 $4.80 7/31/20248,300 shares $2,930.73 -95.8%0.1%0.2 $0.35 7/15/2024199,100 shares $79,440.90 +3.4%2.4%0.4 $0.40 6/30/2024192,500 shares $61,600.00 -5.8%3.5%0.5 $0.32 6/15/2024204,400 shares $135,128.84 -26.7%3.7%0.9 $0.66 5/31/2024278,800 shares $195,438.80 +1,390.9%7.4%1.2 $0.70 5/15/202418,700 shares $14,773.00 +289.6%0.5%0.1 $0.79 4/30/20244,800 shares $4,482.24 -65.5%0.2%0 $0.93 4/15/202413,900 shares $10,925.40 -66.5%0.6%0 $0.79 3/31/202441,500 shares $45,650.00 -2.8%1.2%0.1 $1.10 3/15/202442,700 shares $48,251.00 -29.2%0.3%0 $1.13 2/29/202460,300 shares $81,103.50 -46.8%0.4%0 $1.35 2/15/2024113,300 shares $131,428.00 -3.6%0.8%0.1 $1.16 1/31/2024117,500 shares $364,250.00 +2.1%1.0%0.1 $3.10 1/15/2024115,100 shares $813,757.00 -70.1%0.9%0.1 $7.07 12/31/2023385,000 shares $2.95 million +4,177.8%3.1%0.3 $7.65 12/15/20239,000 shares $19,170.00 -15.1%0.1%0 $2.13 11/30/202310,600 shares $66,462.00 -86.9%0.1%0.8 $6.27 11/15/202380,800 shares $24,240.00 +19.0%0.7%0.5 $0.30 10/31/202367,900 shares $29,197.00 -35.9%0.8%0.4 $0.43 10/15/2023106,000 shares $54,600.60 -32.2%1.2%0.5 $0.52 9/30/2023156,300 shares $110,816.70 -70.2%1.7%0.3 $0.71 9/15/2023523,700 shares $361,143.52 -32.4%5.8%1 $0.69 8/31/2023774,300 shares $497,178.03 +22.5%9.3%1.6 $0.64Virtually Limitless Energy? (Ad)A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discovered a new form of power—what some are calling “Helios” technology. It’s not solar, wind, or even nuclear fission. In fact, it could yield more energy than oil, gas, and coal combined—without harmful byproducts. This obscure company could be at the center of the next trillion-dollar energy revolution.One company’s discovery could change power forever 8/15/2023632,000 shares $391,903.20 +236.0%7.6%1.5 $0.62 7/31/2023188,100 shares $98,000.10 -58.3%2.0%0.5 $0.52 7/15/2023451,200 shares $356,448.00 +1,246.9%5.8%1.2 $0.79 6/30/202333,500 shares $31,155.00 -68.0%0.4%0.1 $0.93 6/15/2023104,800 shares $102,704.00 -38.2%1.4%1.9 $0.98 5/31/2023169,700 shares $154,427.00 +8.3%2.2%1.1 $0.91 5/15/2023156,700 shares $151,999.00 -45.5%2.1%0.2 $0.97 4/30/2023287,700 shares $310,716.00 -2.2%3.8%0.3 $1.08 4/15/2023294,100 shares $294,100.00 -0.6%3.8%0.4 $1.00 3/31/2023295,800 shares $291,363.00 -26.8%3.9%0.4 $0.99 3/15/2023404,000 shares $416,120.00 -62.2%5.3%0.5 $1.03 2/28/20231,070,000 shares $1.92 million +1,716.6%14.1%1.5 $1.79 2/15/202358,900 shares $68,318.11 +79.0%0.8%0.1 $1.16 1/31/202332,900 shares $31,607.03 +6.5%0.4%0.7 $0.96 1/15/202330,900 shares $30,368.52 -62.4%0.4%0.6 $0.98 12/30/202282,100 shares $82,100.00 -22.4%1.1%1.6 $1.00 12/15/2022105,800 shares $102,626.11 -2.0%1.4%2.6 $0.97 11/30/2022108,000 shares $107,211.60 +182.0%1.4%2 $0.99 11/15/202238,300 shares $37,832.74 +20.4%0.5%0.5 $0.99 10/31/202231,800 shares $34,344.00 -14.8%0.4%0.4 $1.08 10/15/202237,300 shares $41,030.00 -37.8%0.5%0.4 $1.10 9/30/202260,000 shares $64,200.00 +210.9%0.8%0.6 $1.07 9/15/202219,300 shares $26,827.00 -61.2%0.3%0.2 $1.39 8/31/202249,700 shares $82,005.00 +343.8%0.6%0.6 $1.65 8/15/202211,200 shares $17,472.00 -5.9%0.1%0.2 $1.56 7/31/202211,900 shares $14,637.00 -48.9%0.2%0.3 $1.23 7/15/202223,300 shares $36,581.00 +20.7%0.3%0.6 $1.57 6/30/202219,300 shares $28,178.00 -49.9%0.3%0.5 $1.46 6/15/202238,500 shares $53,900.00 -20.3%0.5%0.8 $1.40 5/31/202248,300 shares $52,647.00 -43.6%0.7%0.6 $1.09 5/15/202285,600 shares $107,000.00 -14.7%1.1%1 $1.25 4/30/2022100,400 shares $162,648.00 -10.8%1.4%1 $1.62 4/15/2022112,500 shares $199,125.00 -9.4%1.5%0.8 $1.77 3/31/2022124,200 shares $244,674.00 +2,600.0%1.7%0.5 $1.97 3/15/20224,600 shares $6,578.00 -56.6%0.1%0 $1.43 2/28/202210,600 shares $15,158.00 -74.6%0.1%0 $1.43 2/15/202241,700 shares $60,465.00 -38.1%0.6%0.1 $1.45 1/31/202267,400 shares $124,690.00 +786.8%0.9%0.1 $1.85 1/15/20227,600 shares $19,760.00 -90.0%N/A0 $2.60 12/31/202175,700 shares $208,932.00 No Change1.0%0.1 $2.76 CING Short Interest - Frequently Asked Questions What is Cingulate's current short interest? Short interest is the volume of Cingulate shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 171,600 shares of CING short. 4.50% of Cingulate's shares are currently sold short. Learn More on Cingulate's current short interest. What is a good short interest ratio for Cingulate? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CING shares currently have a short interest ratio of 2.0. Learn More on Cingulate's short interest ratio. What is a good short interest percentage for Cingulate? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.50% of Cingulate's floating shares are currently sold short. Is Cingulate's short interest increasing or decreasing? Cingulate saw a increase in short interest in April. As of April 15th, there was short interest totaling 171,600 shares, an increase of 21.7% from the previous total of 141,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Cingulate's float size? Cingulate currently has issued a total of 3,941,000 shares. Some of Cingulate's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Cingulate currently has a public float of 3,810,000 shares. How does Cingulate's short interest compare to its competitors? 4.50% of Cingulate's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Cingulate: Renovaro Inc. (6.62%), Inozyme Pharma, Inc. (10.15%), vTv Therapeutics Inc. (1.55%), Rani Therapeutics Holdings, Inc. (10.27%), Alto Neuroscience, Inc. (14.14%), Metagenomi, Inc. (12.67%), Adaptimmune Therapeutics plc (2.05%), Clearside Biomedical, Inc. (0.73%), InterCure Ltd. (0.10%), Achilles Therapeutics plc (1.26%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks. What does it mean to sell short Cingulate stock? Short selling CING is an investing strategy that aims to generate trading profit from Cingulate as its price is falling. CING shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Cingulate? A short squeeze for Cingulate occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CING, which in turn drives the price of the stock up even further. How often is Cingulate's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CING, twice per month. The most recent reporting period available is April, 15 2025. More Short Interest Resources from MarketBeat Related Companies Renovaro Short Squeeze Inozyme Pharma Short Squeeze vTv Therapeutics Short Squeeze Rani Therapeutics Short Squeeze Alto Neuroscience Short Squeeze Metagenomi Short Squeeze Adaptimmune Therapeutics Short Squeeze Clearside Biomedical Short Squeeze InterCure Short Squeeze Achilles Therapeutics Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CING) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThe collapse has already startedThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTrump announcement boosts “next Bitcoin”President Trump just made his first big crypto move ... Announcing the creation of a national strategic re...Weiss Ratings | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredMassive red flag about American consumerWhy is the U.S. Dollar suddenly crashing? Pundits on either side of the aisle have been warning that the U....Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cingulate Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cingulate With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CING Stock Free CING Stock Alerts